ARTICLE | Clinical News
Embeda morphine/naltrexone regulatory update
November 11, 2013 8:00 AM UTC
Pfizer said FDA approved an update to the manufacturing process of Embeda morphine/naltrexone for managing pain. The process addresses the stability issue that led to the drug's U.S. recall in March 2...